Welltower director awarded 1,056 deferred stock units
Spisso Johnese reported acquisition or exercise transactions in this Form 4 filing.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Spisso Johnese reported acquisition or exercise transactions in this Form 4 filing.
Welltower Inc. director Johnese Spisso received an equity award of 1,056 deferred stock units of common stock. The units were granted on February 26, 2026 without cash consideration under the Amended and Restated Welltower Inc. 2022 Long-Term Incentive Plan.
Each deferred stock unit will be settled in common stock upon vesting on February 26, 2027. After this grant, Spisso now directly holds 16,057 shares of Welltower common stock.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 1,056 | $0.00 | $0.00 |
Footnotes (1)
- F1. These shares represent deferred stock units that were granted without cash consideration on February 26, 2026 under the Amended and Restated Welltower Inc. 2022 Long-Term Incentive Plan. Each deferred stock unit will be settled in common stock upon vesting on February 26, 2027.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Welltower (WELL) director Johnese Spisso report in this Form 4 filing?
Was cash paid for the 1,056 deferred stock units reported by Welltower (WELL) director Johnese Spisso?
When do Johnese Spisso’s deferred stock units in Welltower (WELL) vest and settle?
What plan governs the equity award reported by Welltower (WELL) director Johnese Spisso?
AI-generated analysis. How Rhea-AI works. Not financial advice.